EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 52002XC1025(02)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 September 2002 to 15 October 2002 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 September 2002 to 15 October 2002 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 September 2002 to 15 October 2002 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council)
IO C 258, 25.10.2002, p. 7–11
(ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
52002XC1025(02)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 September 2002 to 15 October 2002 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council)
Official Journal C 258 , 25/10/2002 P. 0007 - 0011
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 September 2002 to 15 October 2002 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC(1) of the European Parliament and of the Council or Article 38 of Directive 2001/82/EC(2) of the European Parliament and of the Council) (2002/C 258/03) - Issuing, maintenance or modification of a national marketing authorisation >TABLE> (1) OJ L 311, 28.11.2001, p. 67. (2) OJ L 311, 28.11.2001, p. 1. ANNEX LIST OF THE INVENTED NAMES OF THE MEDICINAL PRODUCTS, MARKETING AUTHORISATION HOLDERS, STRENGTHS, PHARMACEUTICAL FORMS, ROUTE OF ADMINISTRATION, PACKAGING AND PACKAGE SIZES SIBUTRAMINE CONTAINING MEDICINAL PRODUCTS WITH MARKETING AUTHORISATION IN THE MEMBER STATES >TABLE>